Rüediger Liersch

Six versus eight cycles of bi-weekly CHOP-14 with or without rituximab in elderly patients with aggressive CD20+ B-cell lymphomas: a randomised controlled trial (RICOVER-60)

Michael Pfreundschuh, Jöerg Schubert, Marita Ziepert et al. · The Lancet Oncology · 2008 · 1.1K citations

Hematological Malignancy, Lymphoid Neoplasia, Elderly Patients +7

Combination Chemotherapy With Gemcitabine Plus Oxaliplatin in Patients With Intensively Pretreated or Refractory Germ Cell Cancer: A Study of the German Testicular Cancer Study Group

Christian Kollmannsberger, J. Beyer, Rüediger Liersch et al. · Journal of Clinical Oncology · 2003 · 155 citations · Full text

Tumor immune escape by the loss of homeostatic chemokine expression

Andor Pivarcsi, Anja Müller, Andreas Hippe et al. · Proceedings of the National Academy of Sciences · 2007 · 132 citations · Full text

S100A2 Induces Metastasis in Non–Small Cell Lung Cancer

Etmar Bulk, Bülent Sargin, Utz Krug et al. · Clinical Cancer Research · 2008 · 108 citations

Polatuzumab vedotin as a salvage and bridging treatment in relapsed or refractory large B-cell lymphomas

Nora Liebers, Johannes Duell, Donnacha Fitzgerald et al. · Blood Advances · 2021 · 85 citations · Full text

Cell Therapy, Immunology, Pathology +19